• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属硫蛋白-III 通过与弗林、PC7 和 PKCα 相关联增加 ADAM10 的活性,从而在非淀粉样蛋白加工过程中。

Metallothionein-III increases ADAM10 activity in association with furin, PC7, and PKCα during non-amyloidogenic processing.

机构信息

Department of Toxicology, College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.

College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.

出版信息

FEBS Lett. 2014 Jun 27;588(14):2294-300. doi: 10.1016/j.febslet.2014.05.017. Epub 2014 May 21.

DOI:10.1016/j.febslet.2014.05.017
PMID:24859040
Abstract

A-disintegrin and metalloproteinase 10 (ADAM10) is involved in the generation of amyloid-β (Aβ) during amyloid precursor protein (APP) processing, and has a protective effect against Aβ neurotoxicity. We explored how metallothionein-III (MT-III) is regulated in the non-amyloidogenic pathway to generate soluble APPα (sAPPα). MT-ІІІ increased sAPPα levels and reduced Aβ peptide levels, but did not affect ADAM10 expression. However, MT-III increased the activity of ADAM10. MT-ІІІ-induced sAPPα secretion, and Aβ peptide formation was blocked by specific inhibitors of furin, proprotein convertase7 (PC7), and PKCα. These results demonstrate that MT-ІІІ increases the amount of active ADAM10 in association with furin, PC7 and PKCα.

摘要

解整合素金属蛋白酶 10(ADAM10)参与淀粉样前体蛋白(APP)加工过程中淀粉样β(Aβ)的产生,对 Aβ 神经毒性具有保护作用。我们探讨了金属硫蛋白-III(MT-III)如何在非淀粉样形成途径中受到调节以产生可溶性 APPα(sAPPα)。MT-ІІІ增加了 sAPPα 水平并降低了 Aβ 肽水平,但不影响 ADAM10 的表达。然而,MT-III 增加了 ADAM10 的活性。特定的 furin、前蛋白转化酶 7(PC7)和 PKCα 的抑制剂阻断了 MT-ІІІ 诱导的 sAPPα 分泌和 Aβ 肽的形成。这些结果表明,MT-ІІІ 与 furin、PC7 和 PKCα 一起增加了活性 ADAM10 的数量。

相似文献

1
Metallothionein-III increases ADAM10 activity in association with furin, PC7, and PKCα during non-amyloidogenic processing.金属硫蛋白-III 通过与弗林、PC7 和 PKCα 相关联增加 ADAM10 的活性,从而在非淀粉样蛋白加工过程中。
FEBS Lett. 2014 Jun 27;588(14):2294-300. doi: 10.1016/j.febslet.2014.05.017. Epub 2014 May 21.
2
Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.隐丹参酮通过激活和转位 ADAM10 和蛋白激酶 C-α刺激淀粉样β蛋白前体的非淀粉样生成途径。
J Alzheimers Dis. 2011;25(2):245-62. doi: 10.3233/JAD-2011-102085.
3
Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.过氧化物酶体增殖物激活受体α的激活刺激了ADAM10介导的淀粉样前体蛋白的蛋白水解。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8445-50. doi: 10.1073/pnas.1504890112. Epub 2015 Jun 15.
4
Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.将ADAM10靶向神经母细胞瘤SH-SY5Y细胞中的脂筏会损害淀粉样前体蛋白的淀粉样生成过程。
Brain Res. 2009 Nov 3;1296:203-15. doi: 10.1016/j.brainres.2009.07.105. Epub 2009 Aug 11.
5
Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.在关键时间窗口期间,ADAM10 介导的 APP 失调处理导致脆性 X 综合征中的突触缺陷。
Neuron. 2015 Jul 15;87(2):382-98. doi: 10.1016/j.neuron.2015.06.032.
6
ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.通过 M1 毒蕈碱受体和 PKCα/ε实现 ERK1 非依赖性的β-淀粉样前体蛋白的 α-分泌酶切割。
Mol Cell Neurosci. 2011 Jul;47(3):223-32. doi: 10.1016/j.mcn.2011.04.008. Epub 2011 May 4.
7
Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway.前体蛋白转化酶活性有助于人类细胞中阿尔茨海默病β-淀粉样前体蛋白的加工:激素原转化酶PC7在组成型α-分泌酶途径中作用的证据。
J Neurochem. 1999 Nov;73(5):2056-62.
8
Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.白细胞介素-1α通过α-分泌酶(ADAM-10和ADAM-17)切割人星形胶质细胞中的淀粉样前体蛋白(APP)刺激非淀粉样生成途径,这一过程涉及p38丝裂原活化蛋白激酶。
J Neurosci Res. 2006 Jul;84(1):106-18. doi: 10.1002/jnr.20864.
9
Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.没食子酸辛酯通过雌激素受体介导的 ADAM10 激活显著促进 APP 的抗淀粉样蛋白形成加工。
PLoS One. 2013 Aug 15;8(8):e71913. doi: 10.1371/journal.pone.0071913. eCollection 2013.
10
EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.EGCG 通过雌激素受体介导的 ADAM10 激活促进 APP 的非淀粉样蛋白生成过程。
FEBS Lett. 2010 Oct 8;584(19):4259-67. doi: 10.1016/j.febslet.2010.09.022. Epub 2010 Sep 17.

引用本文的文献

1
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy.蛋白酶触发的生物响应性药物递送用于恶性肿瘤的靶向治疗诊断。
Acta Pharm Sin B. 2021 Aug;11(8):2220-2242. doi: 10.1016/j.apsb.2021.01.017. Epub 2021 Jan 24.
2
GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.GPR40 受体激动剂 TAK-875 可改善 APPswe/PS1dE9 小鼠的认知缺陷并减少 β-淀粉样蛋白生成。
Psychopharmacology (Berl). 2021 Aug;238(8):2133-2146. doi: 10.1007/s00213-021-05837-4. Epub 2021 Jun 26.
3
Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment.
α-分泌酶ADAM10调控:对阿尔茨海默病治疗的见解
Pharmaceuticals (Basel). 2018 Jan 29;11(1):12. doi: 10.3390/ph11010012.
4
The Efficacy and Pharmacological Mechanism of ZnMT3 to Protect against Alzheimer's Disease.锌金属硫蛋白3对阿尔茨海默病的保护作用及其药理机制
Sci Rep. 2017 Oct 23;7(1):13763. doi: 10.1038/s41598-017-12800-x.
5
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.与阿尔茨海默病相关的金属及神经元金属结合蛋白
Oxid Med Cell Longev. 2016;2016:9812178. doi: 10.1155/2016/9812178. Epub 2016 Jan 10.